Hercules Capital, Inc. Common Stock (NY:HTGC)

16.58 UNCHANGED

Delayed Quote Updated: 7:00 PM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Hercules Capital, Inc. Common Stock

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

The 2 Best Stocks For Even Higher Interest Rates ↗

September 19, 2022

Even if the future is messy and it’s hard to guess what will happen, there are investment strategies that will get you through the next couple of years and beyond. Here are two stocks worth a closer...

Via Talk Markets

Hercules Receives a BBB+ Reaffirmed Investment Grade Corporate Rating from Kroll Bond Rating Agency, Inc.

September 13, 2022

From Hercules Capital, Inc.

Via Business Wire

Major Goals For ATAI: $175M Secured In Term Loan Facility, Plus Q2 Earnings Report ↗

August 15, 2022

Clinical-stage psychedelics company ATAI Life Sciences N.V. (NASDAQ: ATAI) announced its financial results for the quarter ended June 30, 2022 and business updates, including a term loan facility...

Via Benzinga

The 2 Best Stocks For The 2022 Recession ↗

August 02, 2022

Let’s take a look at how this recession will affect the giant mega-cap companies that most investors follow, as well as some smaller companies operating in specific business niches. The difference will...

Via Talk Markets

IVERIC bio Shares Jump On Debt Financing To Fund Zimura Launch ↗

July 26, 2022

Via Benzinga

Daily Stock Analysis: Hercules Capital Inc. ↗

July 26, 2022

Hercules Capital Inc. is a small-cap asset management company operating in the financial services business sector.

Via Talk Markets

Beat Rising Rates With These Two Stocks ↗

June 13, 2022

High inflation has become a driving force in our lives. It’s challenging to invest for income and keep up with inflation, especially outside of commodity-focused investments.

Via Talk Markets

Is This 10.7% Yield Too Strong for Its Own Good? ↗

April 27, 2022

Hercules Capital’s dividend situation is a bit unique because it regularly pays a variable supplemental dividend in addition to its quarterly dividend.

Via Talk Markets

Benzinga's Top Ratings Upgrades, Downgrades For July 29, 2022 ↗

July 29, 2022

Via Benzinga

Hercules Capital Reports Second Quarter 2022 Financial Results

July 28, 2022

From Hercules Capital, Inc.

Via Business Wire

Earnings Preview For Hercules Capital ↗

July 27, 2022

Hercules Capital (NYSE:HTGC) is set to give its latest quarterly earnings report on Thursday, 2022-07-28. Here's what investors need to know before the announcement. Analysts estimate that Hercules...

Via Benzinga

Daily Biotech Pulse: EU Approval For AbbVie's Ulcerative Colitis Treatment, Angion Biomedica Evaluates Alternatives, Clinical Hold For Immuron's Bacterial Infection Candidate ↗

July 26, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the Second Quarter of 2022

July 26, 2022

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Increases Its Quarterly Cash Distribution to $0.35 per Share for the Second Quarter of 2022

July 26, 2022

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Announces Date for Release of Second Quarter 2022 Financial Results and Conference Call

July 14, 2022

From Hercules Capital, Inc.

Via Business Wire

What 4 Analyst Ratings Have To Say About Hercules Capital ↗

June 28, 2022

Analysts have provided the following ratings for Hercules Capital (NYSE:HTGC) within the last quarter:

Via Benzinga

Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors

June 24, 2022

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Completes Two Institutional Debt Financings, Raising a Total of $200.0 Million to Support Continued Growth

June 23, 2022

From Hercules Capital, Inc.

Via Business Wire

Akero Therapeutics Shares Surge After Equity Investment From This Famed Large Cap Biopharma ↗

June 16, 2022

Via Benzinga

Hercules Capital Expands Its Credit Facilities to $720 Million to Support Strong Investment Portfolio Growth

June 15, 2022

From Hercules Capital, Inc.

Via Business Wire

Daily Stock Analysis: Hercules Capital ↗

June 02, 2022

Hercules Capital Inc shows a possible 32.09% net gain including a 12.42% forward-looking dividend yield.

Via Talk Markets

Hercules Capital Receives BBB- Investment Grade Credit and Corporate Rating from Fitch Ratings, Inc.

May 10, 2022

From Hercules Capital, Inc.

Via Business Wire

Madrigal Announces Debt Funding Of $250M To Back Potential US Resmetirom Launch ↗

May 09, 2022

Via Benzinga

Hercules Capital Announces Date of 2022 Annual Meeting of Stockholders

May 09, 2022

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Reports First Quarter 2022 Financial Results

May 05, 2022

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Announces Supplemental Cash Distribution of $0.15 per Share for the First Quarter of 2022

May 03, 2022

From Hercules Capital, Inc.

Via Business Wire

Hercules Capital Declares Cash Distribution of $0.33 per Share for the First Quarter of 2022

May 03, 2022

From Hercules Capital, Inc.

Via Business Wire

Expert Ratings for Hercules Capital ↗

April 25, 2022

Over the past 3 months, 4 analysts have published their opinion on Hercules Capital (NYSE:HTGC) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...

Via Benzinga

Hercules Receives a BBB Reaffirmed Investment Grade Corporate Rating From DBRS, Inc.

April 18, 2022

From Hercules Capital, Inc.

Via Business Wire

Benzinga's Top Ratings Upgrades, Downgrades For April 22, 2022 ↗

April 22, 2022

Upgrades

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.